|
Emcure Pharmaceuticals Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
25648.06 Cr.
|
P/BV
|
6.23
|
Book Value (Rs.)
|
217.34
|
|
52 Week High/Low (Rs.)
|
1580/889
|
FV/ML
|
10/1
|
P/E(X)
|
37.64
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.95
|
Div Yield (%)
|
0.22
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 971.35 | 727.23 | 747.22 | 972.55 |
| | | | | |
| Net CashFlow From Operating Activities | 851.71 | 1097.24 | 746.85 | 768.21 |
| Net Cash Used In Investing Activities | -94.00 | -712.51 | -467.69 | -788.79 |
| Net Cash Used From Financing Activities | -813.96 | -164.21 | -145.40 | -151.85 |
| Foreign Exchange Gains / Losses | -2.05 | -2.00 | -0.13 | 0.19 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | 0.00 | 0.00 | 214.12 |
| | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -58.30 | 218.52 | 133.64 | 41.87 |
| Cash And Cash Equivalents Begin of Year | 43.99 | -174.53 | -308.17 | -350.04 |
| Cash And Cash Equivalents End Of Year | -14.31 | 43.99 | -174.53 | -308.17 |
